MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report

    S. Kazanci, M. Afshari, J. Fleisher (Chicago, USA)

    Objective: N/A Background: Levodopa-responsive muscular rigidity is one of the hallmarks of Parkinson’s disease (PD). Many rheumatological conditions can present with stiffness1-4. For example, polymyalgia…
  • 2023 International Congress

    The Synuclein-One Study: Detection of Cutaneous Phosphorylated alpha-synuclein for the Diagnosis of the Synucleinopathies

    R. Freeman, T. Levine, J. Stohl, B. Bellaire, C. Gibbons (BOSTON, USA)

    Objective: The Synuclein-One study is an NIH-funded 30-site, multicenter trial of 428 patients with synucleinopathies  including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple…
  • 2023 International Congress

    Dystonic tremor as main manifestation of a large SCA21 family

    V. Yahya, E. Monfrini, E. Moro, A. Di Fonzo (Milan, Italy)

    Objective: To identify the genetic cause of disease in a French family with multiple members affected by dystonic tremor with autosomal dominant inheritance. Background: Spinocerebellar…
  • 2023 International Congress

    Asymptomatic Gaucher disease presented as Parkinsonism in 61 years old patient.

    E. Basha, E. Ranxha, J. Tana (Tirana, Albania)

    Objective: Gaucher disease is an inherited disease caused by a mutation in the glucocerebrosidase gene, causing visceral, hematologic, and skeletal involvement. [1] [2] We report…
  • 2023 International Congress

    Association of Early and late age of onset with Mitochondrial DNA haplogroup in Indian Spinocerebellar Ataxia type- 2 patients.

    A. Sonakar, M. Srivastava, M. Faruq, A. Srivastava (NEW DELHI, India)

    Objective: To explore the role of mtHaplogroups in early and late onset SCA2 patients. Background: An unstable expansion of a CAG tract in the ATXN2…
  • 2023 International Congress

    Jerky dystonic hand revisited: post-stroke thalamic tremor

    S. Garg, K. Shetty, C. H M, N. Sharma (Bangalore, India)

    Objective: To assess phenomenology and clinical- radiological correlation of post thalamic stroke movement disorders (MDs) Background: Post stroke movement disorders (PSMD) are rare and have…
  • 2023 International Congress

    Post stroke Restless Limb Syndrome and its impact on sleep and life quality in patients in Rural Gujarat, India

    S. Desai, J. Darji, D. Desai (Anand, India)

    Objective: We aimed to assess the prevalence of RLS in patients with brain stroke and assess its impact on sleep and quality of life. We…
  • 2023 International Congress

    Self-perception of symptoms lateralization and association with symptoms severity in Parkinson’s disease.

    V. Silva Costa, T. Figo Rocha, M. Oliveira Menacho, T. Silva Brito, A. Lepesteur Gianlorenço (São Carlos, Brazil)

    Objective: To compare the self-perception of symptoms lateralization with clinical evaluation, and explore associations with symptoms severity, onset side, and handedness. Background: Symptoms lateralization is…
  • 2023 International Congress

    Psilocybin therapy for depression and anxiety associated with Parkinson’s disease: a pilot study (NCT04932434)

    E. Bradley, K. Sakai, G. Fernandes, C. Ludwig, M. Bock, J. Ostrem, C. Tanner, A. O'Donovan, P. Finley, Z. Busby, A. Mckernan, R. Zuzuarregui, A. Penn, A. Wang, A. Theberge, R. Rosen, J. Woolley (San Francisco, USA)

    Objective: To investigate the safety, tolerability, feasibility, and preliminary efficacy of moderate and high dose psilocybin treatment with psychotherapeutic support for comorbid Parkinson's disease (PD)…
  • 2023 International Congress

    Deep brain stimulation for movement disorders: Assessing disparities in access to care

    Z. Rifi, M. Harary, L. Remore, K. Fu, A. Bari (Los Angeles, USA)

    Objective: To investigate the impact of non-disease related factors (sex, race, age, language, or socioeconomic status) on the likelihood of movement disorders patients receiving Deep…
  • « Previous Page
  • 1
  • …
  • 267
  • 268
  • 269
  • 270
  • 271
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley